Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$209.01 - $232.56 $2,926 - $3,255
-14 Reduced 1.18%
1,177 $257,000
Q4 2023

Jan 30, 2024

SELL
$197.69 - $227.29 $38,351 - $44,094
-194 Reduced 14.01%
1,191 $270,000
Q3 2023

Nov 09, 2023

SELL
$201.05 - $221.7 $3,216 - $3,547
-16 Reduced 1.14%
1,385 $278,000
Q2 2023

Aug 02, 2023

SELL
$211.93 - $241.33 $211 - $241
-1 Reduced 0.07%
1,401 $338,000
Q1 2023

May 10, 2023

BUY
$213.32 - $257.83 $2,559 - $3,093
12 Added 0.86%
1,402 $321,000
Q4 2022

Feb 13, 2023

BUY
$203.72 - $248.97 $283,170 - $346,068
1,390 New
1,390 $327,000
Q2 2022

Oct 11, 2022

BUY
$213.86 - $277.87 $5,346 - $6,946
25 Added 2.93%
879 $206,000
Q2 2022

Aug 15, 2022

SELL
$213.86 - $277.87 $39,350 - $51,128
-184 Reduced 17.73%
854 $200,000
Q1 2022

May 10, 2022

BUY
$259.82 - $298.18 $48,846 - $56,057
188 Added 22.12%
1,038 $274,000
Q4 2021

Feb 14, 2022

SELL
$271.6 - $314.21 $10,320 - $11,939
-38 Reduced 4.28%
850 $267,000
Q3 2021

Nov 12, 2021

SELL
$274.82 - $308.34 $56,338 - $63,209
-205 Reduced 18.76%
888 $250,000
Q2 2021

Aug 16, 2021

SELL
$251.87 - $278.14 $56,670 - $62,581
-225 Reduced 17.07%
1,093 $302,000
Q1 2021

May 18, 2021

SELL
$204.88 - $255.03 $177,016 - $220,345
-864 Reduced 39.6%
1,318 $336,000
Q4 2020

Feb 11, 2021

SELL
$186.91 - $214.42 $34,391 - $39,453
-184 Reduced 7.78%
2,182 $444,000
Q3 2020

Nov 13, 2020

SELL
$167.03 - $201.3 $22,382 - $26,974
-134 Reduced 5.36%
2,366 $445,000
Q2 2020

Aug 14, 2020

BUY
$113.31 - $182.44 $63,793 - $102,713
563 Added 29.07%
2,500 $415,000
Q1 2020

May 15, 2020

BUY
$104.32 - $195.28 $202,067 - $378,257
1,937 New
1,937 $245,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Wealth Alliance Portfolio

Follow Wealth Alliance and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Alliance with notifications on news.